Elevated c-reactive protein in patients with obstructive sleep apnea hypopnea syndrome (OSAH) Source: Annual Congress 2007 - Systemic effects of obstructive sleep apnoea Year: 2007
C-reactive protein levels in obstructive sleep apnea syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 356s Year: 2005
Investigation on serum adiponectin levels in patients with obstructive sleep apnea hypopnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 445s Year: 2004
Evaluation of the levels of the ultrasensitive C-reactive protein (CRPus) in subjects with obstructive sleep apnea- hypopnea syndrome Source: International Congress 2019 – Consequences of sleep-disordered breathing from molecular and clinical points of view Year: 2019
High sensitivity C-reactive protein (CRP) in patients with obstructive sleep apnoea syndrome Source: Eur Respir J 2003; 22: Suppl. 45, 566s Year: 2003
S100B protein: A useful marker in obstructive sleep apnea syndrome Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology Year: 2012
Relationship between adiponectin gene polymorphism and obstructive sleep apnea hypopnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 412s Year: 2006
C-reactive protein (CRP) levels in obstructive sleep apnea (OSA) patients and relation to severity of OSA Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011
Elevated c-reactive protein (CRP) levels in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 332s Year: 2004
BNP or VEGF levels do not predict disease severity in obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2005; 26: Suppl. 49, 40s Year: 2005
Association between obstructive sleep apnea hypopnea and metabolic syndromes Source: Eur Respir J 2004; 24: Suppl. 48, 692s Year: 2004
Serum YKL-40 level is associated with apnea hypopnea index in patients with obstructive sleep apnea syndrome Source: International Congress 2014 – Of mice and men: physiology and biology of sleep disordered breathing Year: 2014
Comparison of plasma NT-proBNP level in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep Year: 2008
Socioeconomic status and obstructive sleep apnea hypopnea syndrome (OSAHS) Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009
Does low plasma adiponectin level affect cardiovasculer risk in obstructive sleep apnea syndrome? Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007
Can snoring intensity predict high blood pressure in the obstructive sleep apnea-hypopnea syndrome? Source: Virtual Congress 2021 – From phenotyping to different diagnostic tools for sleep breathing disorders Year: 2021
NT-proBNP in obstructive sleep apnoea (OSA) Source: Eur Respir J 2006; 28: Suppl. 50, 415s Year: 2006
Myeloid-related protein 8/14 levels in children with obstructive sleep apnoea Source: Eur Respir J 2010; 35: 843-850 Year: 2010
Plasma levels of TNF in obstructive sleep apnea syndrome (OSA) before and after surgical intervention Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology Year: 2012
What is the impact of obstructive sleep apnea hypopnea syndrome and daytime sleepiness on work performance? Source: International Congress 2017 – Variation in th phenotypes and symptoms of obstructive sleep apnoea Year: 2017